Health Information & Coding · Independent exam preparation

Certified Rheumatology Coder (CRHC) Preparation Guide Study Guide

Practise rheumatology note abstraction, E/M leveling, procedure bundling, drug-unit calculations and Medicare compliance through focused concepts and original drills.

By CertMedbry · Updated 29 October 2026

60 concepts explainedWorked examples & common pitfallsOfficial blueprint references

Learn to distinguish confirmed diagnoses from outpatient uncertainty, select defensible E/M levels, identify bundled procedure work and convert documented drug quantities into billing units. This selective 60-concept guide supports preparation for AAPC's Certified Rheumatology Coder credential in the United States coding and billing context. The issuer's examination competency outline defines the full scope, including procedures and service categories beyond the examples developed here.

Try 20 free practice questions

What is the exam format?

Check the question types, timing and outline before planning your revision.

How many questions are on the CRHC examination, and what is the passing threshold?

AAPC's certification article specifies 100 multiple-choice questions and a 70% passing threshold. It does not identify a separate scored-question count or disclose a pretest-question allocation. Do not assume an unpublished scored/pretest split.

Certified Rheumatology Coder (CRHC) certification — AAPC Help Center

How long is the examination, and how is it delivered?

AAPC specifies four hours in one sitting, delivered on a computer either at a testing center or at home with a live remote proctor. Its guidance does not describe adaptive delivery. The ACR course page gives a conflicting five-hour-forty-minute examination duration; this guide uses AAPC's examination guidance as the controlling format source.

Certified Rheumatology Coder (CRHC) certification — AAPC Help Center · Certified Rheumatology Coder Course — American College of Rheumatology

Are all examination items multiple choice?

The issuer's certification article describes 100 multiple-choice questions. The 2026 study-guide sample also discusses beta testing of fill-in-the-blank items and provides practice versions with different item styles. It does not establish a fixed fill-in-the-blank allocation for every live CRHC examination. The 20 questions here are independent four-option drills.

Certified Rheumatology Coder (CRHC) certification — AAPC Help Center · 2026 Specialty Study Guide: CRHC — AAPC sample pages

Which outline and code-book dates apply?

AAPC's certification article and 2026 Specialty Study Guide establish the credential identity and examination competencies. The article displays May 23, 2024; neither source gives a separate blueprint effective date. The 2026 guide specifies 2026 code books. For actual encounters beginning October 1, 2026, FY 2027 ICD-10-CM applies. That encounter-date rule does not establish a new AAPC examination blueprint.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Certified Rheumatology Coder (CRHC) certification — AAPC Help Center · ICD-10 — CMS

Which books and examination tools are described by AAPC?

AAPC lists AMA's CPT Professional Edition, ICD-10-CM and HCPCS Level II as approved books. Its article highly recommends current-year books and permits the preceding year, current year or a combination, with one copy of each book. The 2026 study guide specifies 2026 editions and states that an E/M calculator is provided for the online examination.

Certified Rheumatology Coder (CRHC) certification — AAPC Help Center · 2026 Specialty Study Guide: CRHC — AAPC sample pages

Is another coding credential required, and is the ACR course a different certification?

CRHC stands alone: the issuer's study guide states that CPC or COC is not a prerequisite. ACR's course prepares learners for the AAPC credential and is not a separate certification pathway. The issuer encourages experienced rheumatology coders and expects substantial terminology, anatomy, pathophysiology and coding knowledge.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Certified Rheumatology Coder Course — American College of Rheumatology · Certified Rheumatology Coder (CRHC) certification — AAPC Help Center

How should payer rules be applied in examination cases?

The 2026 guide directs candidates to follow CPT guidelines unless a case specifically identifies Medicare coverage. Do not infer Medicare enrollment from age. Medicare scenarios in this guide are labeled explicitly; local coverage information is not treated as a national rule or an all-payer requirement.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Billing and Coding: Trigger Point Injections, A57701 — CMS Medicare Coverage Database

Does this guide cover the entire official examination scope?

No. These 60 concepts provide a selective foundation across all six learning domains. The official outline remains the full scope and includes musculoskeletal and other surgery, laboratory/pathology, radiology, medicine, Category III codes, E/M, diagnosis coding, HCPCS, modifiers and compliance. No numerical domain weights are published, so the concept, question and flashcard distributions are educational choices rather than claimed examination proportions.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Certified Rheumatology Coder (CRHC) certification — AAPC Help Center

CRHC is a standalone specialty coding credential awarded by AAPC and developed with the American College of Rheumatology. Its emphasis is accurate abstraction and coding of rheumatology records. The six learning domains and their distribution here are editorial groupings of the official competencies; AAPC publishes no numerical domain weights in the official outline. The questions and flashcards are independently authored learning materials.

Outline used: AAPC CRHC examination scope verified on 2026-10-11 using the issuer's certification help article and competency outline in its 2026 Specialty Study Guide: CRHC. The guide specifies 2026 code books but gives no separate blueprint effective date or numerical domain weights. The workbook label matches the official credential; no alias or replacement-exam mapping is needed.

60 key concepts: understand, apply and avoid the traps

Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.

ICD-10-CM diagnosis codingnot stated

1.How does outpatient diagnostic uncertainty change code selection?

Outpatient coding reports the highest degree of certainty established for the encounter. Diagnoses described as probable, suspected, rule out or similar uncertainty are not coded as confirmed conditions. Instead, report established diagnoses, signs, symptoms or other reasons for the visit. Read the assessment carefully: a definite diagnosis of inflammatory arthritis can coexist with an uncertain proposed subtype. Retain the confirmed condition without promoting the suspected subtype to certainty.

Apply it

An office assessment states that left wrist pain may represent gout, with further testing planned and no established arthritis diagnosis. Abstract the documented wrist pain rather than assigning confirmed gout merely because testing targets that disease.

Common pitfall: A focused workup or disease-specific treatment can suggest clinical concern, but neither independently converts an explicitly uncertain outpatient diagnosis into a confirmed diagnosis.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 · 2026 Specialty Study Guide: CRHC — AAPC sample pages

2.How does a complete note become verified diagnosis codes and a sequence?

Work from the documented diagnoses through the Alphabetic Index, then verify each candidate in the Tabular List. Consider this office note: 'Visit chiefly for right shoulder stiffness. Assessment: adhesive capsulitis, right shoulder; exercises and physical therapy discussed. Also assessed left forefoot pain: metatarsalgia, left foot; footwear modification advised.' The Index pathway for adhesive capsulitis of the shoulder leads to M75.0; Tabular verification supplies M75.01, Adhesive capsulitis of right shoulder. Metatarsalgia leads to M77.4; verification supplies M77.42, Metatarsalgia, left foot. Both conditions affected care.

Apply it

Sequence M75.01 first because the shoulder condition chiefly occasioned this visit, followed by M77.42 for the separately assessed foot condition. The confirmed capsulitis explains the shoulder symptoms, so do not add a routine shoulder-pain code merely to restate them.

Common pitfall: M75.01 alone omits an additional condition that affected management. Reversing the two codes misrepresents the stated encounter priority. M70.51 describes right knee bursitis and cannot substitute for the documented left foot metatarsalgia.

2026 Specialty Study Guide: CRHC — AAPC sample pages · ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

3.How do etiology and manifestation instructions control sequencing?

Some conditions require multiple codes to describe an underlying disease and its manifestation. A code-first instruction directs sequencing of the underlying condition, while a use-additional-code instruction identifies information needed after the associated condition. Codes titled as manifestations in diseases classified elsewhere generally cannot serve as the first-listed diagnosis. Follow the classification's instructions rather than sequencing solely by which symptom appears most prominent in the narrative.

Apply it

A rheumatology note documents a systemic disease and a linked organ manifestation. Locate both conditions, inspect the code-first and use-additional-code notes, and arrange the required codes according to those instructions before considering ordinary visit-priority sequencing.

Common pitfall: The symptom receiving the most narrative attention does not override a mandatory sequencing convention. A manifestation code may require an underlying disease code first.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

4.Which conditions belong on an outpatient encounter claim?

The first-listed diagnosis ordinarily identifies the condition or reason chiefly responsible for the outpatient services, subject to applicable sequencing instructions. Additional conditions are reported when they coexist and require or affect care, treatment or management. A lengthy problem list is not an automatic list of reportable diagnoses. Distinguish active chronic conditions relevant to today's care from resolved illnesses and historical information that does not affect the encounter.

Apply it

During a visit for active shoulder bursitis, the clinician also adjusts management because of chronic kidney disease. A remote, healed ankle sprain has no effect on care. Evaluate the bursitis and kidney disease for reporting, excluding the irrelevant sprain.

Common pitfall: Copying every historical diagnosis inflates the claim without encounter support. Conversely, a comorbidity can be reportable when it materially affects management despite receiving little narrative space.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 · 2026 Specialty Study Guide: CRHC — AAPC sample pages

5.When should symptoms be reported separately from a definitive diagnosis?

Signs and symptoms routinely associated with an established disease are generally not reported separately unless the classification instructs otherwise. Symptoms that are not routinely associated may be reportable when documented and relevant. This distinction prevents duplicating the same clinical information through both a disease code and its usual manifestations. When no definitive diagnosis is established in an outpatient encounter, the documented symptoms may instead provide the appropriate basis for coding.

Apply it

The clinician confirms a condition that ordinarily accounts for the patient's joint pain and documents no separate pain disorder. Review whether the pain is integral before adding a symptom code solely because pain prompted the visit.

Common pitfall: A symptom's appearance in the chief complaint does not automatically justify separate reporting after a definitive diagnosis explains it. Classification instructions still take precedence.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

6.How do site, laterality and multiple-site options interact?

Musculoskeletal codes frequently distinguish the affected bone, joint or muscle and its laterality. Use a multiple-site code when the classification provides an appropriate one for the documented condition. When no such option exists, separate site-specific codes may be necessary. A disease affecting both sides does not automatically justify an unspecified-site code. Preserve documented detail, and distinguish the anatomical site required by the code from a nearby joint mentioned in the examination.

Apply it

A note identifies the same disorder in the right and left elbows. Check whether the category offers a bilateral or multiple-site option; if it does not, evaluate separate right- and left-sided codes rather than choosing unspecified laterality.

Common pitfall: Multiple affected sites and missing site documentation are different situations. An unspecified code should not replace known sites merely to reduce the number of codes.

2026 Specialty Study Guide: CRHC — AAPC sample pages · ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

7.Which documentation supports a specific rheumatoid arthritis code?

Rheumatoid arthritis classification can depend on documented disease type, rheumatoid factor status, affected sites and associated organ involvement. Abstract the provider's diagnosis and relevant documented relationships, then verify the available code structure. A laboratory result by itself does not authorize the coder to create a new disease subtype or organ complication. Specificity is valuable only when the record supports it; an apparent discrepancy between the diagnosis and other documentation warrants clarification.

Apply it

The assessment names rheumatoid arthritis but does not characterize its serologic subtype. A positive laboratory result appears elsewhere in the chart. Determine whether provider documentation supports the more specific classification before assigning a serology-dependent disease code.

Common pitfall: Do not treat a positive antibody result as permission to infer every associated rheumatoid arthritis classification or attribute an unrelated organ disorder to rheumatoid disease.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 · 2026 Specialty Study Guide: CRHC — AAPC sample pages

8.How should gout specificity be abstracted without inference?

Gout coding distinguishes documented forms and may require information about cause, chronicity, site, laterality or tophus status. Use the established diagnosis rather than treating an elevated serum urate result as proof of gout. A clinical history can support a provider's conclusion, but the coder should not independently diagnose a gout subtype from risk factors or medications. Locate the documented form in the Index and verify all required detail in the Tabular List.

Apply it

A clinician documents chronic gout involving a specified ankle and explicitly notes a tophus. Use those details to evaluate the appropriate code family and laterality, rather than defaulting to an unspecified gout code from memory.

Common pitfall: A drug on the medication list may suggest gout management, but it does not establish the diagnosis, its cause, its chronicity or tophus status.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 · Gout — NIAMS

9.When does osteoporosis require a current pathological fracture code?

Category M80 describes osteoporosis with a current pathological fracture; M81 describes osteoporosis without a current pathological fracture. The fracture site in M80 identifies the fracture location, not a localized distribution of osteoporosis. In a patient with known osteoporosis, a fracture from trauma that would not ordinarily break healthy bone is classified through the osteoporosis-with-fracture pathway. A fully healed previous osteoporosis fracture does not make the present encounter an M80 encounter.

Apply it

A patient with osteoporosis has completed healing of an earlier fragility fracture and is now seen only for osteoporosis management. Consider the without-current-fracture category and the appropriate history code rather than retaining an active fracture classification.

Common pitfall: A past fracture and a current healing fracture are not interchangeable. Do not keep an active pathological fracture code after the fracture has fully healed.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 · 2026 Specialty Study Guide: CRHC — AAPC sample pages

10.How does the phase of fracture care determine the encounter character?

Fracture encounter characters describe the phase of care rather than the number of visits or whether the clinician has seen the patient before. Initial-encounter characters apply during active treatment. Subsequent-encounter characters describe healing or recovery care and may distinguish routine healing, delayed healing, nonunion or malunion. Sequela coding addresses a residual effect after the acute condition has ended. Use the documented care phase and healing status within the applicable fracture category.

Apply it

A patient first visits this rheumatology practice for routine monitoring of a fracture already treated elsewhere. Determine the character from the current healing phase, rather than assigning an initial encounter simply because the patient is new to the practice.

Common pitfall: New patient status is an E/M classification, not a fracture encounter-character rule. The first visit to a new clinician can still represent subsequent fracture care.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

11.How do adverse effects differ from poisoning in drug coding?

An adverse effect occurs when a correctly prescribed drug is properly administered but causes an unwanted reaction. Code the nature of that reaction first, followed by the appropriate drug adverse-effect code. Poisoning involves circumstances such as an overdose, wrong substance or incorrect route; the poisoning code is sequenced before its manifestations. The decisive distinction is how the drug was prescribed and taken, not how severe the resulting symptoms became.

Apply it

The clinician links a new skin eruption to a medication taken exactly as prescribed. Treat the documented reaction as an adverse-effect situation, sequencing the skin condition before the drug code rather than applying poisoning sequencing.

Common pitfall: A severe reaction does not automatically mean poisoning. Correct use with an unwanted effect and incorrect use producing toxicity follow different classification and sequencing rules.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

12.What distinguishes underdosing from a clinician-directed dose reduction?

Underdosing means taking less medication than prescribed or instructed by the manufacturer. It can be intentional or unintentional and does not require a documented worsening of disease. An underdosing code is not sequenced as the first-listed diagnosis; report an associated relapse or exacerbation first when present. A clinician's authorized reduction creates a new prescribed regimen, so following that revised regimen is not underdosing merely because the previous dose was higher.

Apply it

A patient independently takes half the prescribed tablets because of cost, and the clinician documents the resulting disease flare. Evaluate the flare first, followed by the underdosing code and applicable documentation of the reason for taking less.

Common pitfall: Do not label adherence to a newly reduced prescription as underdosing. Compare actual use with the instructions in effect, rather than with an older regimen.

ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

Evaluation and management codingnot stated

13.How is new versus established office patient status determined?

Office patient status depends on whether the patient received professional services within the preceding three years from the reporting physician or qualified healthcare professional, or another physician or professional of the exact same specialty and subspecialty in the same group. It does not depend simply on whether this individual clinician recognizes the patient. A first visit to a different specialty can qualify as new even within the same group practice.

Apply it

A patient previously saw a cardiologist in a multispecialty group but has never received services from its rheumatology clinicians. Assess the rheumatology encounter using the specialty-specific three-year rule rather than treating all group visits as equivalent.

Common pitfall: Changing clinicians within the same specialty and group does not automatically create a new patient. Conversely, sharing a group does not erase a different specialty.

2026 Specialty Study Guide: CRHC — AAPC sample pages · 2023-e-m-descriptors-guidelines.pdf

14.Which elements determine an office E/M level?

For office or other outpatient codes 99202–99205 and 99212–99215, select the level using medical decision making or qualifying total physician or qualified healthcare professional time on the encounter date. Code 99211 is an exception: it is not selected by MDM level or total practitioner time and may describe a service that does not require the practitioner's presence. A medically appropriate history and examination remain part of the applicable service, but their length does not determine the level.

Apply it

A visit contains a long copied review of systems but a straightforward assessment and brief management. Determine the supported MDM or qualifying time for the appropriate practitioner-level office code instead of increasing the level because many history and examination fields are populated.

Common pitfall: Do not apply MDM or practitioner-time thresholds to 99211. Counting examination systems or history elements also does not establish the level of codes selected under the current office MDM-or-time framework.

2023-e-m-descriptors-guidelines.pdf · 2026 Specialty Study Guide: CRHC — AAPC sample pages

15.How does a worked established-patient note support 99214?

Consider this office note: 'Established patient followed for rheumatoid arthritis. Increased hand swelling and morning stiffness now interfere with dressing. Assessment: chronic rheumatoid arthritis with exacerbation, without severe exacerbation or threat to life or bodily function. After assessing response and adverse effects, change prescription therapy and arrange follow-up. No tests or external records reviewed or ordered; no procedure performed.' The addressed chronic illness with exacerbation meets moderate problems. The documented prescription treatment decision meets moderate management risk. Data are minimal or none.

Apply it

Two elements meet moderate: problems and risk. Select 99214 for this established-patient office visit by MDM; no documented total time is needed for that selection. Reject 99213 because low MDM understates the two moderate elements, 99215 because two high elements are absent, and 99204 because that is a new-patient code.

Common pitfall: A medication list alone would not establish prescription management. The decisive evidence is the assessment and treatment decision. Neither the rheumatoid arthritis label nor symptom count independently establishes high MDM.

2023-e-m-descriptors-guidelines.pdf · 2026 Specialty Study Guide: CRHC — AAPC sample pages

16.When does a listed condition count as a problem addressed?

A condition contributes to the problems element when it is evaluated or treated during the encounter, including meaningful consideration in management. Merely copying a diagnosis or noting that another clinician manages it does not establish that it was addressed. Review the assessment and plan for evaluation, treatment decisions or care coordination. Also avoid counting several symptoms of one evaluated disease process as separate problems simply because each symptom has its own name.

Apply it

The rheumatologist evaluates active arthritis and adjusts treatment. Diabetes appears only in the history, with no assessment or effect on decisions. Count the arthritis work without automatically adding diabetes as another addressed problem for MDM.

Common pitfall: A long problem list can exaggerate perceived complexity. Presence in the chart and active evaluation at this encounter are different evidentiary requirements for MDM.

CPT Evaluation and Management revisions FAQs — American Medical Association · 2026 Specialty Study Guide: CRHC — AAPC sample pages

17.Why does unchanged disease not always mean stable disease?

For MDM, stability is assessed against the patient's treatment goals. A chronic illness can remain unchanged yet still be inadequately controlled if those goals are unmet. Conversely, a condition at its individualized target may be stable despite requiring ongoing treatment. Use the clinician's assessment and management context to classify the problem; do not infer stability solely from phrases such as unchanged, doing about the same or no recent deterioration.

Apply it

A clinician documents persistent rheumatoid disease activity above the treatment target and changes therapy, although symptoms have not worsened since the last visit. Recognize that unchanged symptoms do not establish a stable chronic illness in this context.

Common pitfall: No emergency and no recent deterioration do not prove stability. The relevant comparison is the documented treatment goal, rather than only the previous visit.

2026 Specialty Study Guide: CRHC — AAPC sample pages · CPT Evaluation and Management revisions FAQs — American Medical Association

18.How are unique tests counted without duplicating data credit?

MDM data counting focuses on unique tests rather than the number of result lines, specimen tubes or repeated mentions. A laboratory panel identified by one CPT code generally represents one unique test. Ordering and reviewing the same test do not create two separate data credits. Anticipated review is included in the ordering credit, so routine review at a later encounter should not simply be counted again as new ordering-and-review work.

Apply it

The clinician orders a complete blood count and a metabolic panel, then reviews both results. Treat each unique test once for the applicable data category; do not multiply the count by the number of measured components.

Common pitfall: Counting each panel component or counting both the order and its routine review inflates data complexity. Repeated documentation does not create additional unique tests.

CPT Evaluation and Management revisions FAQs — American Medical Association · 2026 Specialty Study Guide: CRHC — AAPC sample pages

19.When does independent interpretation contribute to E/M data?

Independent interpretation means the reporting clinician personally interprets a test performed by another professional when that interpretation is not separately reported. Reading someone else's written report is review, not independent interpretation. Work separately billed as a professional interpretation cannot also be used to increase the E/M data element. Document the clinician's actual interpretive work and distinguish it from a brief acknowledgment that a report was available.

Apply it

The rheumatologist examines outside radiographic images and documents an independent interpretation without separately billing it. Evaluate that work under the applicable MDM data category rather than treating it as identical to reading the radiologist's report.

Common pitfall: The phrase images reviewed does not necessarily demonstrate an independent interpretation. Also exclude interpretation work already represented by a separately reported professional service code.

CPT Evaluation and Management revisions FAQs — American Medical Association · 2026 Specialty Study Guide: CRHC — AAPC sample pages

20.How does prescription management differ from intensive toxicity monitoring?

A documented prescription treatment decision can support moderate management risk. High-risk intensive toxicity monitoring requires a drug capable of causing serious morbidity or death and monitoring directed at those adverse effects, rather than primarily at effectiveness. Monitoring uses laboratory, physiological or imaging tests; history or examination alone does not qualify. It may be short-term or long-term, but long-term monitoring must occur at least quarterly. The monitoring must affect management at the encounter. High management risk alone does not establish overall high MDM.

Apply it

Qualifying example: for a drug with potential life-threatening marrow toxicity, the clinician evaluates CBC surveillance performed every eight weeks and uses the findings to decide whether treatment can continue. Counterexample: asking about nausea and examining the patient, or measuring disease activity solely to assess benefit, does not establish intensive toxicity monitoring.

Common pitfall: Drug potency, cost or a routine laboratory order is insufficient. Establish the serious toxicity, qualifying test method, monitoring frequency and effect on management. Then apply the two-of-three MDM rule independently.

2023-e-m-descriptors-guidelines.pdf

21.Which activities qualify for total office E/M time?

Qualifying office E/M time includes physician or qualified healthcare professional work on the encounter date, both face-to-face and non-face-to-face. Examples include preparing to see the patient, reviewing relevant records, evaluation, counseling, ordering, care coordination and documentation when not separately reported. The clinician need not assign a separate duration to every task, but the total must be supported. Staff work and work on a different date do not enter this total.

Apply it

The physician spends time reviewing records before the visit, counseling the patient and completing documentation that evening. All occur on the encounter date and concern the E/M service, so assess their combined qualifying time rather than face-to-face time alone.

Common pitfall: A time-based office visit is not limited to counseling time. Equally, the entire team's workday cannot be combined into the reporting clinician's total.

Are physicians required to document the time spent on each specific task associated with an outpatient visit? — AMA · CPT Evaluation and Management — American Medical Association

22.How is separately reported procedure time removed from E/M time?

Time spent performing a separately reported service cannot also support time-based E/M selection. Identify whether the documented total includes an injection, aspiration, interpretation or other separately coded work, then remove that portion. The remaining time must independently meet the E/M requirements. This prevents payment for the same work twice. A significant separate E/M service may still be reportable, but its time must remain distinct from the procedure's time.

Apply it

The physician documents 44 total minutes, including 14 minutes performing a separately reported joint procedure. Evaluate 30 minutes for time-based E/M selection, assuming all remaining minutes qualify, rather than using the full 44-minute total.

Common pitfall: Appending modifier 25 does not make procedure minutes available for E/M leveling. Separate reportability and exclusion of overlapping time are independent requirements that both apply.

Are physicians required to document the time spent on each specific task associated with an outpatient visit? — AMA · Medicare NCCI Policy Manual 2026, Chapter I

23.Why must the E/M category be selected before its level?

E/M categories describe different service settings and circumstances, such as office visits, hospital care and consultations. Their descriptors, permitted selection methods and time requirements are not interchangeable. Establish the service location, patient status, encounter purpose and applicable payer context before applying a level. An office time threshold cannot automatically be transferred to a hospital service, and a referral does not by itself establish that consultation requirements have been met.

Apply it

A rheumatologist evaluates a hospitalized patient at another clinician's request. Identify the hospital service category and whether Medicare consultation policy applies before selecting a level; do not begin with the familiar office established-patient code family.

Common pitfall: Correctly identifying moderate MDM does not finish code selection. The same complexity can correspond to different codes depending on the service category and patient circumstances.

CPT Evaluation and Management — American Medical Association · 2026 Specialty Study Guide: CRHC — AAPC sample pages

24.When does a same-day procedure support a separate E/M service?

A minor procedure includes the usual evaluation and decision work associated with performing it. A separate E/M service requires significant, separately identifiable work beyond that included service, with modifier 25 appended to the E/M code when appropriate. A different diagnosis is not inherently required. Evaluate the content of the encounter rather than assuming that every new patient or every procedure decision automatically creates a separately billable E/M service.

Apply it

A scheduled knee injection visit includes only an interval check and examination needed for that injection. Compare this with a visit that also evaluates a separate systemic disease flare and develops a management plan beyond the procedural work.

Common pitfall: A new patient label or a lengthy procedure note does not establish a separate E/M service. The additional assessment and management must be identifiable beyond usual procedural care.

Medicare NCCI Policy Manual 2026, Chapter I · 2026 Specialty Study Guide: CRHC — AAPC sample pages

CPT procedures and modifiersnot stated

25.How does joint size determine the arthrocentesis code family?

Arthrocentesis coding distinguishes small, intermediate and major joints or bursae. Fingers and toes are small; the wrist, elbow and ankle are intermediate; the shoulder, hip and knee are major examples. Select the family from the actual treated structure, then determine whether the service meets an ultrasound-guided descriptor. Pain severity, aspirated volume and medication quantity do not change the joint's classification or justify moving to a larger-joint code.

Apply it

A clinician aspirates a painful wrist without ultrasound guidance. Select the intermediate-joint family despite severe symptoms and a large effusion, because anatomical classification rather than symptom intensity determines the appropriate arthrocentesis size category for this encounter.

Common pitfall: Do not classify joints by how large they appear clinically. The ankle remains an intermediate-joint example even when swelling makes it look larger than expected.

2026 Specialty Study Guide: CRHC — AAPC sample pages

26.Why is aspiration followed by injection reported once for one joint?

The arthrocentesis descriptors include aspiration and/or injection. Consequently, removing fluid and then injecting medication into the same joint are alternatives or combined components within one procedure service, not automatically two separately reportable procedures. The number of syringes or needle manipulations does not change this descriptor logic. When multiple joints are treated, evaluate each joint and the applicable reporting rules separately, preserving site and laterality documentation.

Apply it

The clinician removes fluid from the left knee and then injects medication into that same knee during the encounter. Report the appropriate knee arthrocentesis service once; evaluate any separately reportable supplied medication through HCPCS.

Common pitfall: Using one aspiration code and another injection code for the same joint duplicates work already encompassed by the and/or descriptor, even when separate syringes are used.

2026 Specialty Study Guide: CRHC — AAPC sample pages

27.Which documentation supports ultrasound-guided arthrocentesis?

The ultrasound-guided arthrocentesis codes incorporate ultrasound guidance and require permanent recording and reporting. Documentation should identify the treated structure and demonstrate that guidance was actually used, with the required retained image record and report. Ultrasound availability or a brief statement that a machine was nearby does not establish the guided service. When the integrated guided code applies, do not separately report the ultrasound guidance already included in its descriptor.

Apply it

A knee aspiration uses real-time ultrasound, with saved images and a documented guidance report. Evaluate the integrated major-joint ultrasound-guided code, rather than reporting the unguided knee procedure plus a separate charge for the included guidance.

Common pitfall: An ultrasound examination performed before treatment is not automatically procedural guidance. Distinguish diagnostic imaging from documented needle guidance and the permanent recording and reporting requirements.

2026 Specialty Study Guide: CRHC — AAPC sample pages

28.How does Medicare treat a joint and its surrounding bursae?

Under Medicare NCCI policy, one joint and its surrounding bursae constitute one arthrocentesis unit of service. Treating both the joint and a surrounding bursa does not support additional units merely because they are anatomically distinct targets. This limit applies to the grouped joint region, while genuinely separate joints require their own analysis. Separate punctures, syringes or diagnoses do not change the unit-of-service rule.

Apply it

In a Medicare encounter, the clinician injects the same shoulder joint and its surrounding subacromial bursa without ultrasound guidance. Report one unit of 20610 for the combined arthrocentesis work, rather than two units for the two targets.

Common pitfall: Anatomical distinction alone does not establish separately reportable units under this policy. Modifier 59 cannot justify a second unit for the same joint and its surrounding bursa.

Medicare NCCI Policy Manual 2026, Chapter IV

29.How are trigger-point injections counted by muscle?

Trigger-point injection code selection depends on the number of muscles injected, rather than the number of trigger points, needle entries or medication deposits. Code 20552 describes treatment involving one or two muscles; 20553 describes three or more muscles. Identify each treated muscle in the documentation before choosing the code. These procedure definitions should be distinguished from payer-specific coverage requirements, which may add separate documentation or utilization conditions.

Apply it

Seven trigger points are injected across two documented muscles during one encounter. Select the one-or-two-muscle procedure category rather than the three-or-more category, because the count of treated muscles remains two despite multiple injection sites.

Common pitfall: Counting needle sticks can overstate the procedure category. Also avoid turning one contractor's coverage frequency or examination requirements into universal CPT reporting rules for every payer.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Billing and Coding: Trigger Point Injections, A57701 — CMS Medicare Coverage Database

30.How are facet injection region, levels and included imaging identified?

Facet injection coding distinguishes cervical/thoracic from lumbar/sacral regions and identifies the first, second and third or additional treated levels. Count the documented facet levels, not merely the number of vertebral labels in the note. The standard facet injection codes described in the issuer guide include fluoroscopic or CT guidance, so that guidance is not separately reported. Add-on code selection follows the region and level structure rather than repeating the initial code.

Apply it

The clinician treats the left C4–C5 and C5–C6 facet levels using fluoroscopy. Recognize two cervical levels and assess the first-level code with its second-level add-on, without adding a separate fluoroscopic guidance charge for included imaging.

Common pitfall: Three named vertebrae can define two intervening levels. Do not count each vertebral label as a separately treated facet level or unbundle guidance included in the code.

2026 Specialty Study Guide: CRHC — AAPC sample pages

31.When should an ultrasound-guided facet procedure lead to Category III review?

Category III codes describe specified emerging technologies, services and procedures; they are not simply inferior versions of Category I codes. The issuer guide directs ultrasound-guided facet injection coding to the relevant Category III family, distinguished by spinal region and level. Match the actual technique to its descriptor before choosing a familiar Category I alternative. The presence of a code identifies a reporting classification, not automatic payer coverage or payment.

Apply it

A note describes ultrasound-guided lumbar facet injections. Review the applicable Category III descriptors and level structure instead of selecting a fluoroscopy/CT-based facet code and adding ultrasound as though the imaging methods were interchangeable components of one descriptor.

Common pitfall: Familiarity or expected payment does not justify substituting a different technique's code. Category III availability and payer coverage are separate questions that require separate analysis.

2026 Specialty Study Guide: CRHC — AAPC sample pages

32.How are venipuncture, specimen handling and laboratory testing distinguished?

Obtaining a blood specimen, preparing it for transport and performing the laboratory analysis are different services. Code 36415 describes collection of venous blood by venipuncture; the laboratory test code describes the analysis. Specimen handling has its own descriptor when the documented service meets it. Report only the work actually performed by the billing entity, and distinguish code-description logic from payer policies that may bundle collection or handling.

Apply it

An office draws venous blood and sends the specimen to an outside laboratory that performs the testing. Identify the office's collection work separately from the laboratory's analysis, then assess applicable handling documentation and payer bundling rules.

Common pitfall: Ordering a test does not mean the office performed its analysis. Conversely, the test's existence does not establish that this office collected or handled the specimen.

2026 Specialty Study Guide: CRHC — AAPC sample pages

33.How does synovial fluid analysis differ from joint aspiration?

Joint aspiration obtains fluid; laboratory analysis evaluates the resulting specimen. These are distinct types of work, so the aspiration code does not by itself identify which laboratory studies occurred. Abstract the actual documented tests, such as the requested analysis of the fluid, and identify which entity performed them. A specimen's availability does not establish that every potentially useful test was ordered, performed or reportable by the aspirating practice.

Apply it

The rheumatologist aspirates a knee and sends the fluid to an outside laboratory for specifically ordered studies. Separate the office procedure from the laboratory's performed analyses, avoiding laboratory charges based only on the fact that fluid was collected.

Common pitfall: Do not infer a complete synovial-fluid test package from an aspiration note. Procedure documentation, test orders and evidence of performed laboratory work answer different coding questions.

Certified Rheumatology Coder (CRHC) certification — AAPC Help Center · 2026 Specialty Study Guide: CRHC — AAPC sample pages

34.Which imaging component does modifier 26 identify?

For services divided into professional and technical components, modifier 26 identifies the professional interpretation and report. The technical component represents resources such as equipment and technologist work. A global service includes both components when supported. First confirm that the code permits component reporting, then identify the work supplied by the reporting practice. Ordering an image or reviewing another clinician's report does not itself establish a separately reportable professional interpretation.

Apply it

A hospital supplies the radiographic equipment and technologist, while the rheumatologist provides the documented interpretation and report for a component-eligible service. Evaluate professional-component reporting rather than billing the entire global imaging service through the physician's office.

Common pitfall: Ownership of a clinic or receipt of an outside report does not establish the technical component. Modifier 26 also requires actual professional interpretation work, not merely an order.

2026 Specialty Study Guide: CRHC — AAPC sample pages

35.How does the administered drug affect infusion procedure selection?

Infusion administration coding considers the type of drug or service and documented infusion duration. Some highly complex biologic agents use administration categories associated with chemotherapy and other highly complex drugs even when the patient does not have cancer. Conversely, intravenous administration alone does not justify that category. Identify the agent, the applicable administration guidance and the recorded start and stop times before selecting the procedure and any additional-hour services.

Apply it

A rheumatology patient receives a biologic identified by the applicable guidance as a highly complex drug. Evaluate the corresponding administration family using the documented duration rather than choosing therapeutic infusion solely because the indication is nonmalignant.

Common pitfall: The patient's diagnosis alone does not define the infusion administration category. Neither every biologic nor every intravenous medication should be assigned the same procedure family automatically.

2026 Specialty Study Guide: CRHC — AAPC sample pages

36.Why are initial infusion selection and medically necessary hydration separate decisions?

The initial infusion code reflects the applicable administration rules and purpose of the encounter, not simply whichever substance entered the line first. Additional services use the appropriate sequential, concurrent or additional-time structure when supported. Saline used only as a carrier, diluent or line maintenance is not automatically a separately reportable hydration service. Medically necessary hydration requires its own supported purpose and qualifying administration rather than mere documentation that saline flowed.

Apply it

An infusion encounter includes saline carrying the prescribed medication, with no separate hydration indication. Evaluate the drug administration service and its documented time; do not add hydration merely because the medication was delivered in a saline solution.

Common pitfall: Chronological first does not always mean initial for coding. A bag labeled saline also does not independently establish medically necessary hydration or a separate hydration charge.

2026 Specialty Study Guide: CRHC — AAPC sample pages

37.When can modifier 59 identify a distinct procedural service?

Modifier 59 identifies a distinct procedural service when the circumstances satisfy the relevant edit and documentation requirements. Distinction may involve a separate site, encounter or other qualifying circumstance, but a different diagnosis alone is insufficient. Review whether the edit permits a modifier and whether a more specific applicable modifier describes the situation. Modifier 59 does not authorize unbundling components that remain integral to the same service.

Apply it

Two procedures trigger an NCCI edit, but the operative note describes genuinely separate anatomical services. Review the edit's modifier indicator and the appropriate specific modifier before deciding whether a distinct-service modifier is supported by the documented circumstances.

Common pitfall: A denial is not evidence that modifier 59 belongs on the claim. Separate documentation must establish a qualifying distinction, and some edits cannot be bypassed.

Medicare NCCI Policy Manual 2026, Chapter I

38.How does a bilateral descriptor affect modifier 50 use?

Modifier 50 identifies a bilateral procedure when appropriate for the code and reporting context. It should not be added when the descriptor already states bilateral or both, because the code already represents the two-sided service. Read the complete descriptor rather than assuming that two treated sides always require a modifier. Distinguish a bilateral-service modifier from anatomical laterality modifiers, and apply the relevant reporting instructions to the specific procedure.

Apply it

The selected radiographic code explicitly describes both acromioclavicular joints. Report that bilateral descriptor without adding modifier 50 solely because images were obtained on the right and left sides during the same examination for this encounter.

Common pitfall: Two sides do not always require a bilateral modifier. Appending modifier 50 to a service already defined as bilateral duplicates information contained in the descriptor.

2026 Specialty Study Guide: CRHC — AAPC sample pages

HCPCS Level II codingnot stated

39.Which drug details must match a HCPCS descriptor?

Drug code selection begins with the actual product and its complete HCPCS descriptor, including any specified formulation, route and billing quantity. A familiar generic name is insufficient when different products or routes have different codes. Confirm the code applicable on the service date and separate product identification from unit calculation. An NDC or package label can help identify the supplied product, but it does not replace the HCPCS descriptor.

Apply it

A practice stocks two formulations sharing an ingredient name. Compare the administered product, route and descriptor before calculating units, rather than reusing the code attached to the previous patient's different formulation merely because the ingredient matches.

Common pitfall: Correct arithmetic cannot rescue selection of the wrong product code. A vial's package size and its NDC also do not automatically equal one HCPCS billing unit.

HCPCS Level II Drug and Biological Product Coding Development Manual — CMS

40.How are administered quantities converted into HCPCS billing units?

A HCPCS drug unit is defined by the quantity in the code descriptor, not by the number of vials, syringes or packages opened. Divide the reportable drug quantity by the descriptor quantity using consistent measurement units. For example, a descriptor of 10 mg per unit requires six units for 60 mg. Resolve product and quantity documentation before calculating, and keep administered and reportable discarded amounts distinguishable on the claim.

Apply it

A hypothetical drug descriptor represents 5 mg per billing unit, and the record documents 35 mg administered. Convert the administered amount to seven units; the calculation concerns claim quantity and does not recommend a treatment dose.

Common pitfall: One vial is not necessarily one billing unit. Confusing milligrams with milliliters or skipping the concentration conversion can produce a mathematically neat but incorrect claim quantity.

HCPCS Level II Drug and Biological Product Coding Development Manual — CMS

41.How are administered and discarded single-dose drug amounts separated?

For applicable Medicare separately payable drugs from single-dose containers, documented administered and eligible discarded quantities are reported separately. The administered line represents the amount given; the discarded line carries modifier JW and represents the eligible unused amount. Both quantities must be converted using the HCPCS descriptor. Documentation should connect the labeled container quantity, administered amount and discarded amount, preventing duplicate payment or inclusion of waste that does not qualify.

Apply it

A hypothetical single-dose vial contains 100 mg, with 80 mg administered and 20 mg discarded. At 10 mg per unit, evaluate eight administered units and two JW units on separate lines, assuming Medicare's policy applies.

Common pitfall: Do not place all vial units on the administered line and then add the discarded units again. That would count the same drug quantity twice.

Discarded Drugs and Biologicals — JW and JZ Modifier FAQs — CMS

42.When does Medicare require JZ, including the below-one-billing-unit exception?

For applicable single-dose drug claims, JZ ordinarily identifies zero discarded drug and accompanies the administered line. CMS FAQ 11 also requires JZ when the administered dose is less than one HCPCS billing unit: report the full billing unit on the administered line without a separate JW line, even if a remainder was physically discarded. The billed unit already includes that remainder. Thus, physical disposal does not necessarily create separately reportable JW units.

Apply it

A hypothetical single-dose vial contains 10 mg, the HCPCS unit is 10 mg, and 5 mg is administered while 5 mg is discarded. Report one unit with JZ and no separate JW line. If the entire 10 mg is administered, one unit with JZ also applies under ordinary zero-discard reporting.

Common pitfall: JZ does not invariably prove that no medication was physically discarded. Distinguish physical waste from separately reportable waste, and never add JW units for an amount already included in the administered billing unit.

Discarded Drugs and Biologicals — JW and JZ Modifier FAQs — CMS

43.Why are multiple-dose containers outside the single-dose discard rule?

Medicare's JW/JZ discarded-drug policy applies to specified drugs from single-dose containers or packages, not multiple-dose containers. Container designation is therefore a decisive coding fact, separate from whether staff happened to use the container for only one patient. Do not infer single-dose status from practice habits. Identify the manufacturer's container labeling and the policy's applicability before creating discarded-drug lines or appending a no-discard modifier.

Apply it

A practice opens a labeled multiple-dose vial for one Medicare patient and later discards the remainder. The office's choice to use it once does not convert it into a single-dose container eligible for the single-dose discarded-drug policy.

Common pitfall: Single-patient use and a single-dose container are not synonymous. The actual container designation controls this policy boundary, even when unused medication is physically discarded.

Discarded Drugs and Biologicals — JW and JZ Modifier FAQs — CMS

44.How does manufacturer overfill affect discarded-drug billing?

Manufacturer overfill is drug volume beyond the labeled amount in a container. Medicare does not pay separately for overfill, including overfill that is discarded. Reconcile administered and eligible discarded quantities against the labeled amount rather than increasing billable units because more liquid could be withdrawn. This differs from a genuine unused remainder within the labeled single-dose quantity, which may qualify for discarded-drug reporting when all applicable requirements are met.

Apply it

A vial labeled 100 mg contains an additional small overfill amount. If 80 mg is administered, evaluate eligible discard from the remaining labeled 20 mg; do not enlarge the JW quantity by adding the manufacturer's extra fill.

Common pitfall: Measured leftover volume may exceed eligible billable discard. Separate labeled drug quantity from overfill before converting the remainder into HCPCS units for the claim.

Discarded Drugs and Biologicals — JW and JZ Modifier FAQs — CMS

45.How do drug supply and administration codes represent different work?

A drug supply code identifies the medication quantity furnished, while an administration procedure code identifies the work of giving it. One does not automatically establish the other. Determine who supplied the drug, whether it is separately reportable in the setting and what administration actually occurred. Office documentation should identify the product and amount supplied as well as the procedure. Avoid billing a practice-supplied drug when the practice did not furnish it.

Apply it

A patient receives an office injection using medication furnished by a separate supplier. Evaluate the documented administration service, but do not automatically add an office-purchased drug charge simply because the office performed the injection during that encounter.

Common pitfall: The administration route does not prove ownership of the medication. Likewise, purchasing a drug does not establish that a separately reportable administration service actually occurred.

2026 Specialty Study Guide: CRHC — AAPC sample pages · HCPCS Level II Drug and Biological Product Coding Development Manual — CMS

Billing regulations and compliancenot stated

46.Which care relationship supports Medicare office incident-to billing?

Medicare office incident-to billing requires more than an established patient label. The service must be integral to a physician's professional treatment course, with an established plan and continuing physician involvement, and all applicable setting, personnel and supervision conditions must be met. A qualified professional may provide covered services under their own billing authority when appropriate even if incident-to requirements are not satisfied. Physician review after the visit alone does not establish the required relationship.

Apply it

A patient returns for planned follow-up under a physician-established treatment course, and a nurse practitioner carries out that plan in the office. Evaluate all incident-to requirements rather than assuming the established patient designation alone authorizes physician billing.

Common pitfall: A physician's signature is not a substitute for the required treatment relationship or supervision. Established patient status also does not prove that today's problem follows the existing plan.

Incident To Services & Supplies — CMS

47.How do current direct-supervision rules and new problems affect incident-to eligibility?

Direct supervision requires the supervising physician or other eligible practitioner to be immediately available to provide assistance and direction; presence in the treatment room is unnecessary. Beginning January 1, 2026, Medicare permits this presence through real-time audiovisual communication for applicable services without a 010 or 090 global surgery indicator, including most incident-to services. Audio-only availability does not satisfy this virtual-presence provision. Services with 010 or 090 indicators are excluded from that permission. Supervision alone does not replace an established treatment plan and continuing physician involvement.

Apply it

For an otherwise eligible office follow-up service without a 010 or 090 indicator, immediate audiovisual availability can satisfy the virtual-presence supervision provision; telephone-only availability cannot. If the nurse practitioner instead independently evaluates a new problem and establishes a new plan, the prior treatment course does not automatically support incident-to billing for that work.

Common pitfall: A later countersignature cannot establish immediate availability during the service. Do not extend the audiovisual permission to excluded surgical services or assume that compliant supervision cures the absence of an established plan.

telehealth-faq-updated-02-26-2026.pdf · Incident To Services & Supplies — CMS

48.How is the billing practitioner selected for a time-based split/shared visit?

Medicare split/shared E/M rules apply to qualifying facility services performed by a physician and nonphysician practitioner in the same group. When substantive portion is determined using time, the billing practitioner must perform more than half of the combined qualifying time. Count overlapping joint time only once. This is distinct from office incident-to billing. The record must support each practitioner's participation and the basis for identifying the substantive portion.

Apply it

For a qualifying facility visit, a physician performs 24 distinct minutes and a same-group nurse practitioner performs 18 distinct minutes, with no overlap. The physician exceeds half of the 42-minute total under the time-based substantive-portion method.

Common pitfall: Two clinicians' signatures do not establish the billing practitioner. Do not count shared minutes twice or transfer facility split/shared rules directly to an ordinary office visit.

Evaluation and Management Services, MLN006764, May 2026 — CMS

49.Which time counts when a teaching physician uses time-based E/M selection?

Teaching-physician time rules distinguish the teaching physician's qualifying patient-care work from time a resident spends independently. For a time-based service, do not simply add resident-alone minutes to the teaching physician's total. Time when both are present is not counted twice. Apply the specific teaching-physician requirements and document participation. Educational discussion unrelated to the patient's management does not become billable E/M time merely because it occurs around the encounter.

Apply it

A resident independently evaluates a patient for 20 minutes, followed by 16 minutes with the teaching physician present and participating. Do not create a 36-minute teaching-physician total by adding the resident's independent work to the shared encounter time.

Common pitfall: The resident's note may document important clinical work, but resident-alone minutes do not automatically become teaching-physician time through attestation or retrospective review of the record.

Evaluation and Management Services, MLN006764, May 2026 — CMS

50.How do CPT consultation requirements differ from Medicare reporting?

A CPT consultation requires a documented request for an opinion or advice about a specific problem, the consultant's evaluation and a report back to the requesting professional. A referral for ongoing care is not automatically a consultation. Medicare does not recognize the consultation code families for payment; select the appropriate office or hospital E/M category instead. Determine payer context explicitly, and never infer Medicare enrollment solely from the patient's age.

Apply it

A requesting clinician seeks advice about a diagnostic problem, and the rheumatologist sends a written opinion. If the case explicitly identifies Medicare, choose the appropriate recognized E/M category rather than a consultation code despite the consultation-like clinical process.

Common pitfall: A request alone does not satisfy every CPT consultation element. Conversely, meeting the CPT elements does not make consultation codes payable by Medicare for that encounter.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Evaluation and Management Services, MLN006764, May 2026 — CMS

51.When does modifier 24 identify an unrelated postoperative E/M service?

Modifier 24 identifies an unrelated E/M service by the same physician or qualified healthcare professional during a postoperative period. The documentation must establish that the evaluation concerns a condition unrelated to the procedure's usual postoperative care. Routine follow-up and care included in the global package do not become separately payable because a visit occurred. Distinguish modifier 24 from modifier 25, which addresses a significant separate E/M service on a procedure day.

Apply it

During a procedure's global period, the same clinician evaluates a clearly unrelated new medical problem and documents separate management. Assess modifier 24 on the E/M service rather than treating the encounter as routine postoperative care or using modifier 25 automatically.

Common pitfall: A different date or a new complaint heading does not prove unrelatedness. Documentation must distinguish the E/M work from care included in the procedure's global package.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Medicare NCCI Policy Manual 2026, Chapter I

52.When should an Original Medicare ABN be delivered?

An Advance Beneficiary Notice of Noncoverage is used in specified Original Medicare situations when the provider expects Medicare may deny an otherwise covered type of service for a relevant coverage reason. It must be delivered before the service so the beneficiary can make an informed choice. Identify the particular service, a meaningful reason for expected denial and a reasonable cost estimate. A signature obtained after treatment does not provide that advance choice.

Apply it

An office expects Medicare to deny a planned service because the patient's circumstances may not meet the applicable coverage criteria. Provide a completed notice before the service, explaining the specific concern and estimated cost rather than requesting a blanket signature.

Common pitfall: An ABN is not a universal consent form or a guarantee of payment. A vague warning that Medicare might deny anything does not explain the particular expected denial.

Advance Beneficiary Notice of Non-coverage Tutorial — CMS · FFS ABN — CMS

53.How does an ABN support informed financial choice without creating coverage?

A valid ABN can affect potential beneficiary financial liability when its requirements are satisfied, but it does not make a service medically necessary or change Medicare coverage criteria. The beneficiary must have an understandable explanation and an opportunity to choose among the notice's options before receiving the service. Separate the decision to furnish a service, the payer's coverage determination and the question of who may ultimately be financially responsible.

Apply it

A beneficiary signs an adequately completed notice and elects to receive a service despite the explained likelihood of denial. Continue to report the actual service accurately; the signature does not authorize changing diagnoses to manufacture a covered indication.

Common pitfall: A signed ABN does not cure inaccurate coding, guarantee collectible charges or convert a noncovered circumstance into a covered one. Notice validity and claim accuracy remain separate requirements.

FFS ABN — CMS · Advance Beneficiary Notice of Non-coverage Tutorial — CMS

54.How does HIPAA minimum necessary differ for payment and treatment disclosures?

HIPAA generally requires reasonable efforts to limit protected health information to the minimum necessary for the intended purpose, including applicable payment activities. Policies should define appropriate access and disclosure based on the work being performed. The minimum-necessary standard does not apply to disclosures to, or requests by, healthcare providers for treatment. That exception should not be extended automatically to every payment, administrative or other disclosure involving a healthcare organization.

Apply it

A payer requests records supporting a particular billed procedure. Apply the minimum-necessary standard to the payment disclosure instead of automatically sending the patient's entire unrelated history. Distinguish this request from a treating clinician's request for patient-care information.

Common pitfall: Treatment and payment are different HIPAA purposes. The treatment exception does not justify unrestricted chart disclosure for every claim review, even when the recipient works in healthcare.

Minimum Necessary Requirement — HHS

Medical terminology, anatomy and physiologynot stated

55.Which joint structures help explain rheumatoid synovitis?

Synovium lines the joint and is a central site of inflammation in rheumatoid arthritis. The resulting inflammatory process can contribute to swelling, pain and progressive damage involving cartilage and bone. Recognizing the difference between the synovial lining, articular cartilage and surrounding tissues helps interpret procedure and examination notes. This anatomical understanding supports accurate abstraction, but synovitis alone does not establish rheumatoid arthritis because other conditions can also inflame a joint.

Apply it

An examination documents wrist synovitis while the assessment leaves its cause uncertain. Understand that the finding concerns joint-lining inflammation, then preserve the clinician's diagnostic uncertainty instead of turning the anatomical finding into confirmed rheumatoid arthritis for outpatient coding.

Common pitfall: Synovitis is a finding, not a synonym for rheumatoid arthritis. Anatomical compatibility with a disease does not eliminate the need for a documented diagnosis.

Rheumatoid Arthritis — NIAMS · ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

56.Why is hyperuricemia different from gout?

Gout is an inflammatory disease associated with monosodium urate crystal deposition. Hyperuricemia means an elevated urate level in the blood; it increases the possibility of crystal formation but does not by itself establish gout. Some people with elevated urate never develop gout. This distinction helps the coder avoid converting a laboratory abnormality into a disease diagnosis and explains why the provider's documented clinical conclusion remains essential.

Apply it

An asymptomatic patient has an elevated serum urate result, and the clinician documents hyperuricemia without diagnosing gout. Preserve that distinction during abstraction rather than assigning a gout diagnosis solely because the laboratory value is above the reference interval.

Common pitfall: A biochemical risk factor is not equivalent to symptomatic crystal disease. Do not treat every elevated urate result as a confirmed gout diagnosis or current flare.

Gout — NIAMS

57.How do tendons, ligaments and entheses identify different anatomical targets?

Tendons transmit muscle force to bone, while ligaments connect bones and help stabilize joints. An enthesis is an attachment site where a tendon or ligament anchors to bone. Enthesopathy concerns such an attachment rather than automatically describing the joint cavity itself. These distinctions help interpret site-specific musculoskeletal diagnoses and procedures. Identify the actual structure named by the clinician instead of reducing every nearby painful structure to a joint disorder.

Apply it

A note identifies disease at a tendon attachment near the elbow rather than within the elbow joint. Use the documented structure to guide code searching, and avoid treating the anatomical proximity as evidence that an intra-articular disorder was diagnosed.

Common pitfall: Pain near a joint does not locate pathology inside that joint. Tendon substance, attachment sites, bursae and joint cavities can require different diagnostic or procedural classifications.

2026 Specialty Study Guide: CRHC — AAPC sample pages

58.How does a bursa differ from a joint cavity?

A bursa is a fluid-containing structure that reduces friction between moving tissues; it is anatomically distinct from the joint cavity. Procedure notes should identify whether the clinician treated the joint, a bursa or another surrounding structure. CPT arthrocentesis families include specified joints and bursae, but anatomical distinction does not automatically establish separate payable units. Understand the structure first, then apply the descriptor and any relevant bundling policy.

Apply it

A shoulder note describes a subacromial bursal injection rather than an intra-articular shoulder injection. Preserve that target in abstraction, then select the applicable procedure family and reporting rules without assuming that every shoulder-region injection enters the joint itself.

Common pitfall: Bursal and intra-articular are not interchangeable anatomical terms. However, naming both structures does not alone defeat a payer rule that groups a joint with surrounding bursae.

2026 Specialty Study Guide: CRHC — AAPC sample pages · Medicare NCCI Policy Manual 2026, Chapter IV

59.Why can rheumatoid arthritis require attention beyond the joints?

Rheumatoid arthritis is a systemic autoimmune disease rather than a disorder limited to mechanical joint wear. In addition to synovial inflammation, it can involve tissues outside the joints. This explains why rheumatology records may discuss organ symptoms and broader disease assessment. For coding, possible biological association is not enough: the record must establish the diagnosed manifestation and any required relationship before assigning a disease-with-organ-involvement classification.

Apply it

A patient with rheumatoid arthritis is evaluated for a pulmonary finding. Recognize why extra-articular disease is clinically considered, but do not automatically classify the lung condition as rheumatoid involvement when the clinician has not established that relationship in the assessment.

Common pitfall: Systemic potential is not proof of causation in an individual patient. A coexisting organ disorder may have another cause or remain diagnostically uncertain at the encounter.

Rheumatoid Arthritis — NIAMS · ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

60.How do arthralgia, effusion and arthritis convey different information?

Arthralgia describes joint pain, effusion describes excess fluid in a joint space and arthritis describes joint inflammation. These terms communicate different levels and types of information, so they should not be substituted casually during abstraction. A painful joint can have an effusion without the clinician establishing a specific arthritis subtype. Translate terminology accurately, then apply outpatient certainty rules to distinguish a documented symptom, finding and definitive disease.

Apply it

The clinician records knee pain and an effusion, with the cause still under evaluation. Preserve the documented symptom and finding as appropriate rather than rewriting the assessment as rheumatoid arthritis or gout because either could produce those features.

Common pitfall: A plausible disease mechanism does not authorize diagnostic substitution. Joint pain, fluid accumulation and a named inflammatory disease are related concepts with different coding implications.

2026 Specialty Study Guide: CRHC — AAPC sample pages · ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027

What to focus on during revision

The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.

  • Abstract each note into confirmed diagnoses, relevant symptoms, addressed problems, performed procedures, supplied drugs and payer-specific facts before selecting codes.
  • Build MDM from its three independent elements, then apply the two-of-three rule; distinguish prescription management from intensive toxicity monitoring.
  • Read complete procedure descriptors, including and/or wording, included imaging, joint size, muscle counts and add-on level structure.
  • Convert drug quantities using descriptor units and reconcile labeled quantity, administered quantity, eligible discard and overfill.
  • Separate CPT rules from explicitly identified Medicare requirements, particularly consultations, incident-to services, split/shared visits and NCCI bundling.
  • Use the official competency outline to extend study into procedure categories and service settings beyond this selective guide.

A practical preparation plan

1. Map the official competencies

Mark each official competency against your experience and code-book familiarity. Include laboratory/pathology, imaging, medicine, other surgery and Category III services rather than concentrating exclusively on joint injections.

2. Practise diagnosis abstraction

For each note, identify certainty, site, laterality, relevant relationships and sequencing instructions. Work from the Index through Tabular verification to final codes and sequence; explain why tempting alternative assignments are unsupported.

3. Level E/M with a visible rationale

Identify the correct service category, then document problems, data and risk separately. Derive the actual E/M code from the qualifying elements. Practise time calculations that remove procedure minutes, staff work and work outside the encounter date.

4. Trace procedure descriptors

Work through joint size, ultrasound requirements, aspiration-plus-injection bundling, trigger-point muscle counts and facet levels. Read parenthetical instructions before considering modifiers.

5. Reconcile drug claims

Use hypothetical quantities to practise product identification and unit conversion. Reconcile administered and eligible discarded quantities to labeled single-dose contents, including the below-one-billing-unit JZ exception, then determine whether JW, JZ or neither applies.

6. Resolve payer and compliance boundaries

Compare office incident-to, facility split/shared and teaching-physician scenarios. Add explicit decisions about consultation reporting, postoperative E/M, advance notices and payment-related privacy disclosures.

7. Review errors by governing rule

Complete the independent drills, explain each rejected option and revisit the controlling source. Track whether mistakes arose from abstraction, descriptor reading, arithmetic, sequencing or payer assumptions; do not interpret a practice score as a pass prediction.

Use your sample score as a starting point

The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.

Start the free sample

Official sources and updates

Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.